Testing effectiveness (Phase 2)Study completedNCT00788892What this trial is testingTrial of CPX-351 in Newly Diagnosed Elderly AML PatientsWho this might be right forAcute Myeloid Leukemia Jazz Pharmaceuticals 126
Testing effectiveness (Phase 2)Study completedNCT04230239What this trial is testingClinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid LeukemiaWho this might be right forNewly Diagnosed Secondary or High Risk AML PETHEMA Foundation 59
Large-scale testing (Phase 3)Study completedNCT01696084What this trial is testingPhase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid LeukemiaWho this might be right forHigh Risk Acute Myeloid Leukemia Jazz Pharmaceuticals 309
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199What this trial is testingVenetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCTWho this might be right forAcute Myeloid Leukemia Gruppo Italiano Trapianto di Midollo Osseo 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07469046What this trial is testingVAH vs VA in Newly Diagnosed Elderly AMLWho this might be right forAcute Myeloid Leukemia (AML)Elderly Patients (60-75 Years) Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 308
Post-approval studies (Phase 4)Study completedNCT01463150What this trial is testingPrasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)Who this might be right forPlatelet Reactivity University of Patras 27